COPPINI, RAFFAELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.895
EU - Europa 7.822
AS - Asia 4.577
SA - Sud America 685
Continente sconosciuto - Info sul continente non disponibili 212
AF - Africa 118
OC - Oceania 62
Totale 23.371
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.663
PL - Polonia 2.151
RU - Federazione Russa 1.971
IT - Italia 1.787
SG - Singapore 1.261
CN - Cina 1.161
HK - Hong Kong 622
BR - Brasile 526
VN - Vietnam 513
IE - Irlanda 414
KR - Corea 334
SE - Svezia 334
DE - Germania 237
FR - Francia 216
FI - Finlandia 165
GB - Regno Unito 159
IN - India 141
CA - Canada 136
BD - Bangladesh 110
JO - Giordania 103
ID - Indonesia 93
CH - Svizzera 92
UA - Ucraina 67
JP - Giappone 60
AR - Argentina 59
AU - Australia 59
TR - Turchia 54
NL - Olanda 53
MX - Messico 42
ES - Italia 41
BE - Belgio 38
ZA - Sudafrica 30
EC - Ecuador 26
IQ - Iraq 23
CI - Costa d'Avorio 19
GR - Grecia 18
VE - Venezuela 18
CO - Colombia 15
NG - Nigeria 15
CL - Cile 14
PK - Pakistan 14
AT - Austria 12
MA - Marocco 12
LT - Lituania 11
JM - Giamaica 10
KE - Kenya 10
PH - Filippine 10
RO - Romania 9
CR - Costa Rica 8
MY - Malesia 8
PY - Paraguay 8
UZ - Uzbekistan 8
DZ - Algeria 7
EG - Egitto 7
KZ - Kazakistan 7
PE - Perù 7
PT - Portogallo 7
CZ - Repubblica Ceca 6
DO - Repubblica Dominicana 6
HN - Honduras 6
KW - Kuwait 6
NP - Nepal 6
SA - Arabia Saudita 6
GE - Georgia 5
HU - Ungheria 5
TT - Trinidad e Tobago 5
AL - Albania 4
BJ - Benin 4
BO - Bolivia 4
DK - Danimarca 4
IL - Israele 4
NI - Nicaragua 4
NO - Norvegia 4
UY - Uruguay 4
AZ - Azerbaigian 3
BB - Barbados 3
BY - Bielorussia 3
GT - Guatemala 3
KG - Kirghizistan 3
NZ - Nuova Zelanda 3
PR - Porto Rico 3
SK - Slovacchia (Repubblica Slovacca) 3
TN - Tunisia 3
AE - Emirati Arabi Uniti 2
AO - Angola 2
CG - Congo 2
GY - Guiana 2
IR - Iran 2
MK - Macedonia 2
MU - Mauritius 2
SR - Suriname 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
TW - Taiwan 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BH - Bahrain 1
BN - Brunei Darussalam 1
Totale 23.134
Salva come PNG Salva come JPEG
Città #
Warsaw 2.141
Santa Clara 1.742
Ashburn 1.299
Singapore 897
Fairfield 742
Hong Kong 541
San Jose 438
Dublin 404
Chandler 369
Woodbridge 343
Seoul 330
Seattle 321
Florence 304
Cambridge 299
Milan 277
Houston 275
Beijing 265
Wilmington 245
Hefei 226
Ann Arbor 217
Council Bluffs 203
Ho Chi Minh City 155
Rome 140
Los Angeles 135
Dallas 132
Buffalo 131
Lawrence 128
Altamura 124
Munich 124
The Dalles 109
Lauterbourg 106
New York 106
Hanoi 103
Princeton 99
Bern 83
Moscow 78
Mumbai 74
Jakarta 68
Boston 65
Helsinki 64
Shanghai 64
Chicago 60
San Diego 60
Dong Ket 57
Medford 57
Phoenix 55
São Paulo 54
Tokyo 53
Melbourne 48
Boardman 46
Kent 46
Bologna 43
Turku 43
Clifton 41
Montreal 36
Naples 36
Orem 36
Brussels 35
Falls Church 35
Frankfurt am Main 33
Paris 33
London 31
Toronto 29
Barcelona 27
Figino 27
Istanbul 26
Norwalk 24
Redondo Beach 24
Rio de Janeiro 23
Turin 23
Lappeenranta 21
Abidjan 19
Guangzhou 19
Da Nang 18
Dearborn 18
Andover 17
Atlanta 17
Denver 17
Johannesburg 17
Palermo 17
Redwood City 17
Scandicci 17
Mexico City 16
Abuja 14
Bengaluru 14
Brooklyn 14
Chennai 14
Falkenstein 14
Poplar 14
Washington 14
Amsterdam 13
Miano 13
Nanjing 13
Nuremberg 13
Brasília 12
Haiphong 12
Tianjin 12
Hillsboro 11
Las Vegas 11
Mudanya 11
Totale 15.556
Salva come PNG Salva come JPEG
Nome #
Ipertensione arteriosa LINEE GUIDA REGIONE TOSCANA 600
"Tuscany Registry for sAdden Cardiac DEath": metodo per la creazione di un registro multicentrico per la gestione di eventi di morte improvvisa in età giovanile 501
Novel insights on the relationship between T-tubular defects and contractile dysfunction in a mouse model of hypertrophic cardiomyopathy. 443
Atrial Remodeling in Hypertrophic Cardiomyopathy 414
Optogenetics design of mechanistically-based stimulation patterns for cardiac defibrillation. 383
Pathogenesis of hypertrophic cardiomyopathy is mutation rather than disease specific: A comparison of the cardiac troponin T E163R and R92Q mouse models 358
Regulation of intracellular Na+ in health and disease: pathophysiological mechanisms and implications for treatment 335
Comparison of long-term outcome in anthracycline-related versus idiopathic dilated cardiomyopathy: a single centre experience 320
Oleuropein aglycone protects against MAO-A-induced autophagy impairment and cardiomyocyte death through activation of TFEB. 318
Myocardial Dysfunction in Hypertrophic Cardiomyopathy: Primary Effects of Sarcomeric Mutations Versus Secondary EC-Coupling Remodelling 307
Late sodium current inhibitors to treat exercise induced obstruction in hypertrophic cardiomyopathy: an in vitro study in human myocardium. 305
Electrical defects of the transverse-axial tubular system in cardiac diseases 290
Altered Ca2+ and Na+ homeostasis in human hypertrophic cardiomyopathy: Implications for arrhythmogenesis 288
Optical investigation of action potential and calcium handling maturation of hiPSC-cardiomyocytes on biomimetic substrates 285
T-Tubular Electrical Defects Contribute to Blunted β-Adrenergic Response in Heart Failure. 284
Defining the diagnostic effectiveness of genes for inclusion in panels: the experience of two decades of genetic testing for hypertrophic cardiomyopathy at a single center 283
Modelling genetic diseases for drug development: Hypertrophic cardiomyopathy 268
Quantitative assessment of passive electrical properties of the cardiac T-tubular system by FRAP microscopy 268
A Novel Method of Isolating Myofibrils From Primary Cardiomyocyte Culture Suitable for Myofibril Mechanical Study 266
Electrophysiological and Contractile Effects of Disopyramide in Patients With Obstructive Hypertrophic Cardiomyopathy: a Translational Study 256
Liquid Crystalline Networks toward Regenerative Medicine and Tissue Repair 251
Design of muscle contraction assist devices by liquid crystalline elastomers 250
Action potential propagation in transverse-axial tubular system is impaired in heart failure 243
Development of Light-Responsive Liquid Crystalline Elastomers to Assist Cardiac Contraction 239
Long-Term Prevalence of Systolic Dysfunction in MYBPC3 Versus MYH7-Related Hypertrophic Cardiomyopathy 236
Selective Blockade of HCN1/HCN2 Channels as a Potential Pharmacological Strategy Against Pain 236
Real-time optical manipulation of cardiac conduction in intact hearts 235
Arrhythmia susceptibility in a rat model of acute atrial dilation 233
SODIUM-DEPENDENT GLUCOSE TRANSPORTERS (SGLT) IN HUMAN ISCHEMIC HEART: A NEW POTENTIAL PHARMACOLOGICAL TARGET 229
Calcium handling maturation and adaptation to increased substrate stiffness in human iPSC-derived cardiomyocytes: The impact of full-length dystrophin deficiency 221
Pharmacological treatment of hypertrophic cardiomyopathy: current practice and novel perspectives 214
Impact of Mavacamten on Force Generation in Single Myofibrils from Rabbit Psoas and Human Cardiac Muscle 212
Chronic Atrial Fibrillation Alters the Functional Properties of Ifin the Human Atrium 211
Ranolazine prevents phenotype development in a mouse model of hypertrophic cardiomyopathy 211
Impact of detubulation on force and kinetics of cardiac muscle contraction 208
UDP-glucose enhances outward K+currents necessary for cell differentiation and stimulates cell migration by activating the GPR17 receptor in oligodendrocyte precursors 206
Advances in Stem Cell Modeling of Dystrophin-Associated Disease: Implications for the Wider World of Dilated Cardiomyopathy 205
Impact of Genotype on the Occurrence of Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy. 204
Reversible dilated cardiomyopathy: into the thaumaturgy of the heart - Part 2 203
[Molecular targets and novel pharmacological options to prevent myocardial hypertrophic remodeling] 202
Pharmacological inhibition of serine proteases to reduce cardiac inflammation and fibrosis in atrial fibrillation 201
Slower Calcium Handling Balances Faster Cross-Bridge Cycling in Human MYBPC3 HCM 200
Representativeness of the "Fiesole Misurata" study database for use in pharmaco-epidemiological investigations on adherence to antihypertensive medications 200
Functional cardiac imaging by random access microscopy 200
The transverse-axial tubular system of cardiomyocytes. 199
Late Sodium Current Inhibition Reverses Electro-Mechanical Dysfunction in Human Hypertrophic Cardiomyopathy 198
BPS2025 - Long-term effect of Mavacamten impact force and sarcomere density in a MYBPC3 iPSC-cardiomyocyte model of hypertrophic cardiomyopathy 197
[Consensus document and recommendations for the prevention of cardiovascular disease in Italy - 2018] 194
Whole heart cytoarchitecture at micron-scale resolution 194
Optical clearing in cardiac imaging: A comparative study 194
Optogenetic manipulation of cardiac electrical dynamics using sub-threshold illumination: dissecting the role of cardiac alternans in terminating rapid rhythms 192
R4496C RyR2 mutation impairs atrial and ventricular contractility 192
Real-World Use and Predictors of Response to Disopyramide in Patients with Obstructive Hypertrophic Cardiomyopathy 191
Anti-hypertensive drugs deprescribing: an updated systematic review of clinical trials 190
Design of Biocompatible Liquid Cristal Elastomers Reproducing the Mechanical Properties of Human Cardiac Muscle 190
Novel Approach Targeting the Complex Pathophysiology of Hypertrophic Cardiomyopathy: The Impact of Late Sodium Current Inhibition on Exercise Capacity in Subjects with Symptomatic Hypertrophic Cardiomyopathy (LIBERTY-HCM) Trial 189
Genetic characterization of juvenile sudden cardiac arrest and death in Tuscany: The ToRSADE registry 187
Efficacy and safety of dysopiramide in patients with obstructive hypertrophic cardiomyopathy 185
Defects in T-tubular electrical activity underlie local alterations of calcium release in heart failure 184
Time resolved depression of isometric force by Mavacamten in single myofibrils from rabbit psoas and human cardiac muscle 183
Efficacy of Ranolazine in Patients With Symptomatic Hypertrophic Cardiomyopathy: The RESTYLE-HCM Randomized, Double-Blind, Placebo-Controlled Study 180
Optogenetic confirmation of transverse‐tubular membrane excitability in intact cardiac myocytes 179
Reply to entcheva: The impact of T-tubules on action potential propagation in cardiac tissue 178
Mavacamten depresses human atrial contractility in the same EC50% range as human ventricle 177
Cardiac safety assessment of a novel recombinant bispecific antibody targeting the ether-à-go-go related gene 1 (hERG1)-β1 integrin macromolecular complex 174
Paradoxical prolongation of QT interval during exercise in patients with hypertrophic cardiomyopathy: cellular mechanisms and implications for diastolic function 173
Clinical and Molecular Aspects of Cardiomyopathies: Emerging Therapies and Clinical Trials 171
Cardiomyocyte-specific Gq signalling and arrhythmias: Novel insights from DREADD technology 171
Altered calcium regulation in isolated cardiomyocytes from Egr-1 knock-out mice 170
Genotype-Driven Pathogenesis of Atrial Fibrillation in Hypertrophic Cardiomyopathy: The Case of Different TNNT2 Mutations 170
Contraction and electrophysiological abnormalities in myofilament mutation-positive and mutation-negative human HCM myocardium 169
Histopathological comparison of intramural coronary artery remodeling and myocardial fibrosis in obstructive versus end-stage hypertrophic cardiomyopathy 168
Dexpramipexole blocks Nav1.8 sodium channels and provides analgesia in multiple nociceptive and neuropathic pain models 166
Sex-Specific Classification of Drug-Induced Torsade de Pointes Susceptibility Using Cardiac Simulations and Machine Learning 165
Impact of RyR2 mutation responsible for Cathecolaminergic Polymorphic Ventricular Tachycardia (CPTV) on the short term interval-force relationship of atrial and ventricular myocardium 165
Cellular determinants of arrhythmic rysk in hypertrophic cardiomyopathy 165
Structural Mapping of Action Potential Propagation Pathways through Healthy and Diseased Heart 163
Role of quantitative myocardial positron emission tomography for risk stratification in patients with hypertrophic cardiomyopathy: a 2016 reappraisal 160
Response to Letter Regarding Article, "Late Sodium Current Inhibition Reverses Electromechanical Dysfunction in Human Hypertrophic Cardiomyopathy" 160
Electrophysiological and molecular remodeling in septal myocytes from fHCM patients 157
Isolation and functional characterization of human ventricular cardiomyocytes from fresh surgical samples. 157
Ion Channel Impairment and Myofilament Ca2+ Sensitization: Two Parallel Mechanisms Underlying Arrhythmogenesis in Hypertrophic Cardiomyopathy 156
Pathophysiology and Treatment of Hypertrophic Cardiomyopathy: New Perspectives 156
Impact of R4496C RyR2 mutation on myocardial contractility 155
Pharmacological Management of Hypertrophic Cardiomyopathy: From Bench to Bedside 155
Content of mitochondrial calcium uniporter (MCU) in cardiomyocytes is regulated by microRNA-1 in physiologic and pathologic hypertrophy 154
1473Microvascular coronary disease and myocardial fibrosis within the spectrum of hypertrophic cardiomyopathy: a histopathologic study 153
Mavacamten has a differential impact on force generation in myofibrils from rabbit psoas and human cardiac muscle 153
Clinical phenotype and outcome of hypertrophic cardiomyopathy associated with thin-filament gene mutations. 152
Targets for therapy in sarcomeric cardiomyopathies. 151
Consensus document and recommendations for the prevention of cardiovascular disease in Italy - 2018 Abstracts 151
Neural Effects on Cardiac Electrophysiology 147
Mechanisms of pro-arrhythmic abnormalities in ventricular repolarisation and anti-arrhythmic therapies in human hypertrophic cardiomyopathy 147
Clinical research in neonates and infants: Challenges and perspectives 145
Effects of ranolazine on the arrhythmic substrate in hypertrophic cardiomyopathy 142
Electrophysiological mechanisms underlying T wave pseudonormalisation on stress ECGs in hypertrophic cardiomyopathy 141
T-tubule remodeling in human hypertrophic cardiomyopathy 141
Amelioration of diastolic dysfunction by dapagliflozin in a non-diabetic model involves coronary endothelium 137
Transthyretin aggregates affect viability and functional properties of cardiomyocytes. 135
Letter to the Editor 135
Totale 21.425
Salva come PNG Salva come JPEG
Categoria #
all - tutte 63.225
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 63.225
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022800 0 0 78 41 50 51 51 46 49 65 149 220
2022/20231.973 165 364 102 116 122 306 234 104 268 27 63 102
2023/2024885 37 91 111 37 52 127 51 179 17 54 50 79
2024/20255.732 237 658 376 805 1.465 694 132 385 294 138 242 306
2025/20267.556 715 958 667 819 826 267 765 387 527 482 275 868
2026/2027934 253 191 490 0 0 0 0 0 0 0 0 0
Totale 23.371